HTG Molecular Diagnostics Inc (OTCPK:HTGMQ)
$ 0.0002 -0.000199 (-99.5%) Market Cap: - Enterprise Value: -2.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q1 2020 HTG Molecular Diagnostics Inc Earnings Call Transcript

May 13, 2020 / 08:30PM GMT
Release Date Price: $65.36 (-9.47%)
Operator

Greetings and welcome to the HTG Molecular Diagnostics, Inc. First Quarter 2020 Earnings Call. (Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Monique Kosse. Thank you. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator. Earlier today, HTG released financial results for the first quarter ended March 31, 2020.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws including statements regarding expected additional collaborations with pharma customers in 2020, anticipated growth in the company's RUO profiling business and related revenue, expected growth in and benefit from pharma programs and collaborations, product development and commercialization activities.

These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control, including uncertainties regarding the ongoing COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot